Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer

Lopez-Beltran, Antonio and Cimadamore, Alessia and Blanca, Ana and Massari, Francesco and Vau, Nuno and Scarpelli, Marina and Cheng, Liang and Montironi, Rodolfo (2021) Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer. Cancers, 13 (1). p. 131. ISSN 2072-6694

[thumbnail of cancers-13-00131-v2.pdf] Text
cancers-13-00131-v2.pdf - Published Version

Download (875kB)

Abstract

In this review, we examined relevant clinical trial results with immune checkpoint inhibitors in patients with metastatic urothelial cancer. We also focused on the potential of immunotherapy in the adjuvant and neoadjuvant setting or as part of drug combinations. Finally, we briefly review the current landscape of biomarkers of response to immune checkpoint inhibitors, such as programmed death-ligand 1 (PD-L1) expression, tumor mutation burden, molecular subtypes of bladder cancer, and immune-gene expression profiling.

Item Type: Article
Subjects: Oalibrary Press > Medical Science
Depositing User: Managing Editor
Date Deposited: 26 Nov 2022 04:52
Last Modified: 02 Jul 2024 12:41
URI: http://asian.go4publish.com/id/eprint/342

Actions (login required)

View Item
View Item